Mpox Passed on Without Symptoms? New Research Shows It’s Possible
In a new study of more than 8,000 men, about 1% of the men tested positive despite never having had symptoms.
Is Doxy PEP Responsible for a Drop in STI Rates in San Francisco?
New data shows that cases of bacterial STIs have dropped dramatically in San Francisco. Public health officials in the city believe doxy PEP has helped drive these declines.
Fewer Women Are Getting Prenatal Care (and Missing an Important Chance to Prevent Congenital Syphilis)
A new report shows that fewer women are getting prenatal care. That means too many patients are missing the chance to prevent congenital syphilis.
Condoms Unfurled—Musings on a Accessible and Valuable Part of Your Safer Sex Toolbox
Condoms. All sorts of shapes, sizes, colors (even glow-in-the-dark). Ribbed or plain. Lubed or not. Latex or plastic. ASHA’s Fred Wyand shares his thoughts on this reliable way to prevent STIs and pregnancy.
Syphilis Rates in Pregnant Women Continue to Rise
Syphilis rates in pregnant women went up 222% percent between 2016 and 2022 and another 28% between 2022 and 2024. Too many pregnant women are not being screened.
Learn About Condoms
Currently, condoms are the only widely available, proven method for preventing pregnancy and reducing transmission of HIV and other sexually transmitted infections (STIs) during sex. Condoms work.
HPV Screening with Self Collection Endorsed by Three Organizations
Three organizations—ACS, ACOG, and HRSA—have each recently endorsed new guidelines for cervical cancer screening. All of them discuss screening with self collected samples.
Is One Shot of the HPV Vaccine Enough?
Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.
Australia is Closer to Ending Cervical Cancer
Australia has been a leader in cervical cancer prevention for decades and is now close to eliminating the disease.
Good News! There Are Two New Drugs to Treat Gonorrhea
The FDA approved two new drugs to treat gonorrhea. The new drugs—gepotidacin and zoliflodacin—are both new kinds of antibiotics and represent the first completely new treatment options in over thirty years.
